- DocumentUntitleduploaded byDarian Herascu
- DocumentUntitleduploaded byDarian Herascu
- Document9782807313170uploaded byDarian Herascu
- DocumentChimie-organique-Exercices-et-problèmes-1977-3.561-1uploaded byDarian Herascu
- Documentsynthesis-characterization-and-antioxidant-activity-studies-of-new-azo-compoundsuploaded byDarian Herascu
- DocumentQPURES_Volume 14_Issue 4_Pages 132-136uploaded byDarian Herascu
- Documentcatalysts-03-00954uploaded byDarian Herascu
- Documentmoradiuploaded byDarian Herascu
- DocumentPIIS240584402030116Xuploaded byDarian Herascu
- Documentsynthesis-of-novel-azo-dyes-derived-from-8hydroxyquinoline-1uploaded byDarian Herascu
- Document--1uploaded byDarian Herascu
- Document1548927980uploaded byDarian Herascu
- Documentfull58158-1uploaded byDarian Herascu
- DocumentBIR39.pdfuploaded byDarian Herascu
- DocumentAnalysis_of_recent_pharmaceutical_regulauploaded byDarian Herascu
- DocumentLanDOMuploaded byDarian Herascu
- DocumentIJAC2021-5558651uploaded byDarian Herascu
- DocumentThe_role_of_assay_methods_in_characterizing_the_quuploaded byDarian Herascu
- Document2022-2uploaded byDarian Herascu
- Documentfphar-10-00125uploaded byDarian Herascu
- DocumentCardiovasc Drugs Ther Nitrates 2011 (2)uploaded byDarian Herascu
- DocumentReport_analysis QA Pharmaceutical Procurement Policies_EU Donors_FVuploaded byDarian Herascu
- Document66546-Article Text-134331-1-10-20110525uploaded byDarian Herascu
- Documentchapter4_01-2011_en_0uploaded byDarian Herascu
- Documentqualitative-and-quantitative-pharmaceutical-analysis-novel-hand-held-miniatur-white-papers-books-en-2uploaded byDarian Herascu
- DocumentPharmaceuticals 15 00400 1uploaded byDarian Herascu
- DocumentIdentification--synthesis-and-characterization-of-an-unknown_2014_Journal-ofuploaded byDarian Herascu
- DocumentUltra-performance-liquid-chromatography-electrospray-ionizat_2014_Journal-ofuploaded byDarian Herascu
- DocumentPioglitazone--A-review-of-analytical-met_2014_Journal-of-Pharmaceutical-Analuploaded byDarian Herascu
- DocumentCBS104_Euploaded byDarian Herascu
- DocumentGlobal-Pharmaceutical-and-Biologics-Regulatory-Strategy-Second-Edition-Sample-Chapter-1uploaded byDarian Herascu
- DocumentA-205uploaded byDarian Herascu
- Document1-s2.0-S1359644621003287-main-1uploaded byDarian Herascu
- Documentjaoac1908-1uploaded byDarian Herascu
- Documentjaoac1908uploaded byDarian Herascu
- DocumentPHARM-24-1-1uploaded byDarian Herascu
- DocumentBJSTR.MS.ID.000109uploaded byDarian Herascu
- Documentcop_article_496630-1uploaded byDarian Herascu
- DocumentTrs957 Annex1 Goodpractices Harmaceuticalqualitycontrol Laboratories 1uploaded byDarian Herascu
- Document13-19-PBuploaded byDarian Herascu
- Documentvarianta_079uploaded byDarian Herascu
- DocumentBJSTR.MS.ID.000109uploaded byDarian Herascu
- DocumentYelle Sudheer Kumar-1uploaded byDarian Herascu
- DocumentSample Chapteruploaded byDarian Herascu
- Documentpolymers-13-02701-v2uploaded byDarian Herascu
- DocumentGJPPS.MS.ID.555564-1uploaded byDarian Herascu
- Documentpolymers-13-02701-v2uploaded byDarian Herascu
- Documentcop_article_496630-1uploaded byDarian Herascu
- Documentart00001-1uploaded byDarian Herascu